![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 5
Zeitschriftenartikel
Burkhardt, Gerrit; Kumpf, Ulrike; Crispin, Alexander; Goerigk, Stephan; Andre, Elisabeth; Plewnia, Christian; Brendel, Bettina; Fallgatter, Andreas; Langguth, Berthold; Abdelnaim, Mohamed; Hebel, Tobias; Normann, Claus; Frase, Lukas; Zwanzger, Peter; Diemer, Julia; Kammer, Thomas; Schönfeldt-Lecuona, Carlos; Kamp, Daniel; Bajbouj, Malek; Behler, Nora; Wilkening, Anja; Nenov-Matt, Tabea; Dechantsreiter, Esther; Keeser, Daniel; Bulubas, Lucia; Palm, Ulrich; Blankenstein, Christiane; Mansmann, Ulrich 
ORCID: https://orcid.org/0000-0002-9955-8906; Falkai, Peter ORCID: https://orcid.org/0000-0003-2873-8667; Brunoni, Andre R; Hasan, Alkomiet und Padberg, Frank
(2023):
Transcranial direct current stimulation as an additional treatment to selective serotonin reuptake inhibitors in adults with major depressive disorder in Germany (DepressionDC): a triple-blind, randomised, sham-controlled, multicentre trial.
In: Lancet, Bd. 402, Nr. 10401: S. 545-554
ORCID: https://orcid.org/0000-0002-9955-8906; Falkai, Peter ORCID: https://orcid.org/0000-0003-2873-8667; Brunoni, Andre R; Hasan, Alkomiet und Padberg, Frank
(2023):
Transcranial direct current stimulation as an additional treatment to selective serotonin reuptake inhibitors in adults with major depressive disorder in Germany (DepressionDC): a triple-blind, randomised, sham-controlled, multicentre trial.
In: Lancet, Bd. 402, Nr. 10401: S. 545-554
Strube, Wolfgang; Aksar, Aslihan; Bauer, Ingrid; Barbosa, Susana; Benros, Michael; Blankenstein, Christiane; Campana, Mattia; Davidovic, Laetitia; Glaichenhaus, Nicolas; Falkai, Peter; Gorlitz, Thomas; Hansbauer, Maximilian; Heilig, Daniel; Khalfallah, Olfa; Leboyer, Marion; Martinuzzi, Emanuela; Mayer, Susanne; Moussiopoulou, Joanna; Papazova, Irina; Peric, Natasa; Wagner, Elias; Schneider-Axmann, Thomas; Simon, Judit und Hasan, Alkomiet
(2022):
Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trial.
In: Journal of Neural Transmission, Bd. 130, Nr. 8: S. 1039-1048
Lorenzen, Sylvie; Quante, Michael; Rauscher, Isabel; Slotta-Huspenina, Julia; Weichert, Wilko; Feith, Marcus; Friess, Helmut; Combs, Stefanie E.; Weber, Wolfgang A.; Haller, Bernhard; Angele, Martin; Albertsmeier, Markus; Blankenstein, Christiane; Kasper, Stefan; Schmid, Roland M.; Bassermann, Florian; Schwaiger, Markus; Liffers, Sven-Thorsten und Siveke, Jens T.
(2022):
PET-directed combined modality therapy for gastroesophageal junction cancer: Results of the multicentre prospective MEMORI trial of the German Cancer Consortium (DKTK).
In: European Journal of Cancer, Bd. 175: S. 99-106
Multhoff, Gabriele; Seier, Sophie; Stangl, Stefan; Sievert, Wolfgang; Shevtsov, Maxim; Werner, Caroline; Pockley, A. Graham; Blankenstein, Christiane; Hildebrandt, Martin; Offner, Robert; Ahrens, Norbert; Kokowski, Konrad; Hautmann, Matthias; Roedel, Claus; Fietkau, Rainer; Lubgan, Dorota; Huber, Rudolf; Hautmann, Hubert; Duell, Thomas; Molls, Michael; Specht, Hanno; Haller, Bernhard; Devecka, Michal; Sauter, Andreas und Combs, Stephanie E.
(2020):
Targeted Natural Killer Cell-Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial.
In: Clinical Cancer Research, Bd. 26, Nr. 20: S. 5368-5379
Specht, Hanno M.; Ahrens, Norbert; Blankenstein, Christiane; Duell, Thomas; Fietkau, Rainer; Gaipl, Udo S.; Günther, Christine; Gunther, Sophie; Habl, Gregor; Hautmann, Hubert; Hautmann, Matthias; Huber, Rudolf Maria; Molls, Michael; Offner, Robert; Rödel, Claus; Rödel, Franz; Schütz, Martin; Combs, Stephanie E. und Multhoff, Gabriele
(2015):
Heat shock protein 70 (Hsp70) peptide activated Natural Killer (NK) cells for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCTx) - from preclinical studies to a clinical phase II trial.
In: Frontiers in Immunology, Bd. 6, UNSP 162
[PDF, 812kB]